Journal of the American Heart Association · 2026
Longitudinal Validation of a Deep Learning Index for Aortic Stenosis Progression.
СтатьяВалидационное исследованиеМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Jiesuck, Kim Jiyeon, Yoon Yeonyee E, Jeon Jaeik, Lee Seung-Ah, Choi Hong-Mi, Hwang In-Chang, Cho Goo-Yeong, Chang Hyuk-Jae, Park Jae-Hyeong
Аннотация
BACKGROUND: Aortic stenosis (AS) is a progressive disease requiring timely monitoring and intervention. While transthoracic echocardiography remains the diagnostic standard, deep learning-based approaches offer the potential for improved disease tracking. This study examined the longitudinal changes in a previously developed deep learning-derived index for AS continuum (DLi-ASc) and assessed its prognostic association with progression to severe AS.
METHODS: We retrospectively analyzed 2373 patients (7371 transthoracic echocardiographies) from 2 tertiary hospitals. DLi-ASc (scaled 0-100), derived from parasternal long-axis and short-axis views, was tracked longitudinally. The median follow-up duration was 42.8 (interquartile range, 22.2-75.7) months.
RESULTS: DLi-ASc increased in parallel with worsening AS stages (P for trend<0.001) and showed strong correlations with aortic valve maximal velocity (Pearson correlation coefficient, 0.69; P<0.001) and mean pressure gradient (Pearson correlation coefficient, 0.66; P<0.001). Higher baseline DLi-ASc was associated with a faster AS progression rate (P for trend<0.001). Additionally, the annualized change in DLi-ASc, estimated using linear mixed-effect models, correlated strongly with the annualized progression of aortic valve maximal velocity (Pearson correlation coefficient, 0.71, P<0.001) and mean pressure gradient (Pearson correlation coefficient, =0.68; P<0.001). In Fine-Gray competing risk models, baseline DLi-ASc was independently associated with progression to severe AS, even after adjustment for aortic valve maximal velocity or mean pressure gradient (hazard ratios per 10-point increase, 2.38 and 2.80, respectively).
CONCLUSIONS: DLi-ASc increased in parallel with AS progression and was independently associated with severe AS progression. These findings support its role as a noninvasive imaging-based digital marker for longitudinal AS monitoring and risk stratification.
METHODS: We retrospectively analyzed 2373 patients (7371 transthoracic echocardiographies) from 2 tertiary hospitals. DLi-ASc (scaled 0-100), derived from parasternal long-axis and short-axis views, was tracked longitudinally. The median follow-up duration was 42.8 (interquartile range, 22.2-75.7) months.
RESULTS: DLi-ASc increased in parallel with worsening AS stages (P for trend<0.001) and showed strong correlations with aortic valve maximal velocity (Pearson correlation coefficient, 0.69; P<0.001) and mean pressure gradient (Pearson correlation coefficient, 0.66; P<0.001). Higher baseline DLi-ASc was associated with a faster AS progression rate (P for trend<0.001). Additionally, the annualized change in DLi-ASc, estimated using linear mixed-effect models, correlated strongly with the annualized progression of aortic valve maximal velocity (Pearson correlation coefficient, 0.71, P<0.001) and mean pressure gradient (Pearson correlation coefficient, =0.68; P<0.001). In Fine-Gray competing risk models, baseline DLi-ASc was independently associated with progression to severe AS, even after adjustment for aortic valve maximal velocity or mean pressure gradient (hazard ratios per 10-point increase, 2.38 and 2.80, respectively).
CONCLUSIONS: DLi-ASc increased in parallel with AS progression and was independently associated with severe AS progression. These findings support its role as a noninvasive imaging-based digital marker for longitudinal AS monitoring and risk stratification.